2 ms·
His point was more along the lines of it being poorly designed. Evolution isn't going to nicely separate functionality into clean, single-purpose biochemical p
by ethbr0 6y ago
His point was more along the lines of it being poorly designed.
Evolution isn't going to nicely separate functionality into clean, single-purpose biochemical pathways.
It's going to overload something that it already has to support a new feature, leading to a rat's nest of intertwined effects.
The hard part in drug development isn't affecting your target: that's pretty easy to guarantee with modern tools. It's finding out that that target also governs 10 other, completely unrelated bodily functions.
- landryraccoon 6y ago> It's going to overload something that it already has to support a new feature, Some companies in the valley just call that Wednesday.=)
- ethbr0 6y agoAbsolutely, which gives me a chuckle when people trivialize biology, but run screaming from a (gasp!) 20 year old legacy codebase.